Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2009 1
2010 1
2011 2
2012 3
2013 4
2014 3
2016 2
2017 1
2018 5
2019 2
2020 6
2021 6
2022 3
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy.
Wei J, Long L, Zheng W, Dhungana Y, Lim SA, Guy C, Wang Y, Wang YD, Qian C, Xu B, Kc A, Saravia J, Huang H, Yu J, Doench JG, Geiger TL, Chi H. Wei J, et al. Among authors: zheng w. Nature. 2019 Dec;576(7787):471-476. doi: 10.1038/s41586-019-1821-z. Epub 2019 Dec 11. Nature. 2019. PMID: 31827283 Free PMC article.
Multi-omics analysis of human mesenchymal stem cells shows cell aging that alters immunomodulatory activity through the downregulation of PD-L1.
Gao Y, Chi Y, Chen Y, Wang W, Li H, Zheng W, Zhu P, An J, Duan Y, Sun T, Liu X, Xue F, Liu W, Fu R, Han Z, Zhang Y, Yang R, Cheng T, Wei J, Zhang L, Zhang X. Gao Y, et al. Among authors: zheng w. Nat Commun. 2023 Jul 20;14(1):4373. doi: 10.1038/s41467-023-39958-5. Nat Commun. 2023. PMID: 37474525 Free PMC article.
Syntheses and Transformations of Sulfoximines.
Zheng W, Chen X, Chen F, He Z, Zeng Q. Zheng W, et al. Chem Rec. 2021 Feb;21(2):396-416. doi: 10.1002/tcr.202000134. Epub 2020 Dec 23. Chem Rec. 2021. PMID: 33369096 Review.
T cell metabolism in homeostasis and cancer immunity.
Wei J, Zheng W, Chapman NM, Geiger TL, Chi H. Wei J, et al. Among authors: zheng w. Curr Opin Biotechnol. 2021 Apr;68:240-250. doi: 10.1016/j.copbio.2021.02.003. Epub 2021 Mar 4. Curr Opin Biotechnol. 2021. PMID: 33676144 Free PMC article. Review.
The first successful expanded compassionate use of Iptacopan in a patient with paroxysmal nocturnal hemoglobinuria.
Han B, Ji J, Zhang B, Bai H, Zhou D, Feng F, Huang Y, Zhu H, Chen L, Wu Z, Jiang X, Li X, Jia Q, Chang Q, Pan H, Peng H, Zheng W, Huang H, Chen Z, Yang C, Chen M, Du B, Zhang S. Han B, et al. Among authors: zheng w. Ann Hematol. 2022 Nov;101(11):2537-2539. doi: 10.1007/s00277-022-04933-5. Epub 2022 Aug 15. Ann Hematol. 2022. PMID: 35965286 Free PMC article. No abstract available.
Modulation of PI3K signaling to improve CAR T cell function.
Zheng W, Jones LL, Geiger TL. Zheng W, et al. Oncotarget. 2018 Nov 9;9(88):35807-35808. doi: 10.18632/oncotarget.26334. eCollection 2018 Nov 9. Oncotarget. 2018. PMID: 30533195 Free PMC article. No abstract available.
Functionalization of in vivo tissue-engineered living biotubes enhance patency and endothelization without the requirement of systemic anticoagulant administration.
Yan H, Cheng Q, Si J, Wang S, Wan Y, Kong X, Wang T, Zheng W, Rafique M, Li X, He J, Midgley AC, Zhu Y, Wang K, Kong D. Yan H, et al. Among authors: zheng w. Bioact Mater. 2023 Mar 14;26:292-305. doi: 10.1016/j.bioactmat.2023.03.003. eCollection 2023 Aug. Bioact Mater. 2023. PMID: 36950151 Free PMC article.
Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL.
Talleur AC, Qudeimat A, Métais JY, Langfitt D, Mamcarz E, Crawford JC, Huang S, Cheng C, Hurley C, Madden R, Sharma A, Suliman A, Srinivasan A, Velasquez MP, Obeng EA, Willis C, Akel S, Karol SE, Inaba H, Bragg A, Zheng W, Zhou SM, Schell S, Tuggle-Brown M, Cullins D, Patil SL, Li Y, Thomas PG, Zebley C, Youngblood B, Pui CH, Lockey T, Geiger TL, Meagher MM, Triplett BM, Gottschalk S. Talleur AC, et al. Among authors: zheng w. Blood Adv. 2022 Nov 8;6(21):5737-5749. doi: 10.1182/bloodadvances.2021006293. Blood Adv. 2022. PMID: 35446934 Free PMC article. Clinical Trial.
42 results